Morphological and inflammatory changes in visceral adipose tissue during obesity

Endocrine Pathology

Volumn 25, Issue 1, 2014, Pages 93-101

  Revelo, Xavier S ^a   Luck, Helen ^a,c   Winer, Shawn ^a,b   Winer, Daniel A ^a,b,c,d,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MaRS Centre   (Canada)

Author keywords

Diabetes; Immunology; Inflammation; Obesity; Visceral adipose tissue

Indexed keywords

ADAPTIVE IMMUNITY; ADIPOCYTE; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; EOSINOPHIL; EXTRACELLULAR MATRIX; HUMAN; HYPOXIA; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; INTRAABDOMINAL FAT; LIVER CELL; MACROPHAGE; METABOLIC DISORDER; MORPHOLOGY; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; PATHOLOGY;

HUMANS; INFLAMMATION; INTRA-ABDOMINAL FAT; OBESITY;

EID: 84900330031     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-013-9288-1     Document Type: Review

References (105)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser, 2000. 894: p. i-xii, 1-253.
2. Gualillo, O., Mediators of inflammation in obesity and its comorbidities. Mediators Inflamm, 2010. 2010.
3. Kahn, S.E., R.L. Hull, and K.M. Utzschneider, Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 2006. 444 (7121): p. 840-6.
4. Khandekar, M.J., P. Cohen, and B.M. Spiegelman, Molecular mechanisms of cancer development in obesity. Nat Rev Cancer, 2011. 11 (12): p. 886-95.
5. Masuoka, H.C. and N. Chalasani, Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci, 2013. 1281 : p. 106-22.
6. Rask-Madsen, C. and C.R. Kahn, Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol, 2012. 32 (9): p. 2052-9.
7. Wild, S., et al., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004. 27 (5): p. 1047-53.
8. Wronska, A. and Z. Kmiec, Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf), 2012. 205 (2): p. 194-208.
9. Khan, T., et al., Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol, 2009. 29 (6): p. 1575-91.
10. Divoux, A. and K. Clement, Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes Rev, 2011. 12 (5): p. e494-503.
11. Yarak, S. and O.K. Okamoto, Human adipose-derived stem cells: current challenges and clinical perspectives. An Bras Dermatol, 2010. 85 (5): p. 647-56.
12. Mortensen, S.B., et al., Membrane-tethered delta-like 1 homolog (DLK1) restricts adipose tissue size by inhibiting preadipocyte proliferation. Diabetes, 2012. 61 (11): p. 2814-22.
13. Arner, P., Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab, 2005. 19 (4): p. 471-82.
14. Skurk, T., et al., Relationship between adipocyte size and adipokine expression and secretion. J Clin EndocrinolMetab, 2007. 92 (3): p. 1023-33.
15. Meyer, L.K., et al., Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity. Adipocyte, 2013. 2 (4): p. 217-26.
16. Traustadottir, G.A., et al., Preadipocytes proliferate and differentiate under the guidance ofDelta-like 1 homolog (DLK1). Adipocyte, 2013. 2 (4): p. 272-5.
17. Spalding, K.L., et al., Dynamics of fat cell turnover in humans. Nature, 2008. 453 (7196): p. 783-7.
18. Pasarica, M., et al., Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab, 2009. 94 (12): p. 5155-62.
19. Mariman, E.C. and P. Wang, Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci, 2010. 67 (8): p. 1277-92.
20. Huang, G., et al., alpha3(V) collagen is critical for glucose homeostasis in mice due to effects in pancreatic islets and peripheral tissues. J Clin Invest, 2011. 121 (2): p. 769-83.
21. Szendroedi, J. and M. Roden, Ectopic lipids and organ function. Curr Opin Lipidol, 2009. 20 (1): p. 50-6.
22. Sell, H. and J. Eckel, Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care, 2010. 13 (4): p. 366-70.
23. Cao, Y., Angiogenesis modulates adipogenesis and obesity. J Clin Invest, 2007. 117 (9): p. 2362-8.
24. Cao, Y., Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov, 2010. 9 (2): p. 107-15.
25. Brakenhielm, E., et al., Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res, 2004. 94 (12): p. 1579-88.
26. Barnhart, K.F., et al., A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med, 2011. 3 (108): p. 108ra112.
27. Hotamisligil, G.S., N.S. Shargill, and B.M. Spiegelman, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 1993. 259 (5091): p. 87-91.
28. Weisberg, S.P., et al., Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 2003. 112 (12): p. 1796-808.
29. Xu, H., et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest, 2003. 112 (12): p. 1821-30.
30. Chawla, A., K.D. Nguyen, and Y.P. Goh, Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol, 2011. 11 (11): p. 738-49.
31. Olefsky, J.M. and C.K. Glass, Macrophages, inflammation, and insulin resistance. Annu Rev Physiol, 2010. 72 : p. 219-46.
32. Mathis, D., Immunological goings-on in visceral adipose tissue. Cell Metab, 2013. 17 (6): p. 851-9.
33. Osborn, O. and J.M. Olefsky, The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med, 2012. 18 (3): p. 363-74.
34. Liu, J., et al., Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med, 2009. 15 (8): p. 940-5.
35. Elgazar-Carmon, V., et al., Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res, 2008. 49 (9): p. 1894-903.
36. Talukdar, S., et al., Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med, 2012.
37. Winer, S., et al., Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med, 2009. 15 (8): p. 921-9.
38. Nishimura, S., et al., CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med, 2009. 15 (8): p. 914-20.
39. Winer, D.A., et al., B cells promote insulin resistance through modulation of Tcells and production of pathogenic IgG antibodies. Nat Med, 2011. 17 (5): p. 610-7.
40. Feuerer, M., et al., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med, 2009. 15 (8): p. 930-9.
41. Wu, D., et al., Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science, 2011. 332 (6026): p. 243-7.
42. Molofsky, A.B., et al., Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med, 2013. 210 (3): p. 535-49.
43. Jenkins, S.J., et al., Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science, 2011. 332 (6035): p. 1284-1288.
44. Jenkins, S.J., et al., IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. The Journal of Experimental Medicine, 2013.
45. Lumeng, C.N., J.L. Bodzin, and A.R. Saltiel, Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest, 2007. 117 (1): p. 175-84.
46. Lumeng, C.N., et al., Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes, 2007. 56 (1): p. 16-23.
47. Odegaard, J.I., et al., Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature, 2007. 447 (7148): p. 1116-20.
48. Kawakami, T., et al., Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and functions. J Immunol, 2013. 191 (6): p. 3358-72.
49. Stienstra, R., et al., Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue. J Biol Chem, 2008. 283 (33): p. 22620-7.
50. Satoh, T., et al., Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature, 2013. 495 (7442): p. 524-8.
51. Aouadi, M., et al., Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice. Proc Natl Acad Sci U S A, 2013. 110 (20): p. 8278-83.
52. Han, M.S., et al., JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science, 2013. 339 (6116): p. 218-22.
53. Brinkmann, V., et al., Neutrophil extracellular traps kill bacteria. Science, 2004. 303 (5663): p. 1532-5.
54. Yang, H., et al., Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol, 2010. 185 (3): p. 1836- 45.
55. Strissel, K.J., et al., T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring), 2010. 18 (10): p. 1918-25.
56. McGillicuddy, F.C., et al., Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem, 2009. 284 (46): p. 31936-44.
57. Dobrian, A.D., et al., Signal transducer and activator of transcription (STAT) 4 deficiency reduces obesity induced insulin resistance and adipose tissue inflammation. Diabetes, 2013.
58. Morris, D.L., et al., Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes, 2013. 62 (8): p. 2762-72.
59. Duffaut, C., et al., Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun, 2009. 384 (4): p. 482-5.
60. Jagannathan, M., et al., Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia, 2010. 53 (7): p. 1461-71.
61. DeFuria, J., et al., B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A, 2013. 110 (13): p. 5133-8.
62. Cipolletta, D., et al., Tissular T(regs): a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. Semin Immunol, 2011. 23 (6): p. 431-7.
63. Tiemessen, M.M., et al., CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A, 2007. 104 (49): p. 19446-51.
64. Ilan, Y., et al., Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proceedings of the National Academy of Sciences, 2010. 107 (21): p. 9765-9770.
65. Cipolletta, D., et al., PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature, 2012. 486 (7404): p. 549-53.
66. Priceman, S.J., et al., Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A, 2013. 110 (32): p. 13079-84.
67. Nishimura, S., et al., Adipose natural regulatory B cells negatively control adipose tissue inflammation. Cell metabolism, 2013.
68. Rossjohn, J., et al., Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol, 2012. 12 (12): p. 845-57.
69. Ji, Y., et al., Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem, 2012. 287 (17): p. 13561-71.
70. Schipper, H.S., et al., Natural killer Tcells in adipose tissue prevent insulin resistance. J Clin Invest, 2012. 122 (9): p. 3343-54.
71. Lynch, L., et al., Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity, 2012. 37 (3): p. 574-87.
72. Subramanian, S., et al., Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res, 2013. 54 (10): p. 2831-41.
73. Wu, L., et al., Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc Natl Acad Sci U S A, 2012. 109 (19): p. E1143-52.
74. Lynch, L., et al., Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol, 2009. 39 (7): p. 1893-901.
75. Mallevaey, T. and T. Selvanantham, Strategy of lipid recognition by invariant natural killer T cells: ' one for all and all for one'. Immunology, 2012. 136 (3): p. 273-82.
76. Elinav, E., et al., Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol, 2006. 209 (1): p. 121-8.
77. Mantell, B.S., et al., Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity. PLoS One, 2011. 6 (6): p. e19831.
78. Kotas, M.E., et al., Impact of CD1d deficiency on metabolism. PLoS One, 2011. 6 (9): p. e25478.
79. Satoh,M., et al., Type II NKTcells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One, 2012. 7 (2): p. e30568.
80. Ji, Y., et al., Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem, 2012. 287 (29): p. 24378-86.
81. Wu, L. and L.Van Kaer, Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance. Adipocyte, 2013. 2 (1): p. 12-16.
82. Cinti, S., et al., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research, 2005. 46 (11): p. 2347-2355.
83. Prieur, X., et al., Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes, 2011. 60 (3): p. 797-809.
84. Shapiro, H., et al., Adipose tissue foam cells are present in human obesity. J Clin Endocrinol Metab, 2013. 98 (3): p. 1173-81.
85. Strissel, K.J., et al., Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes, 2007. 56 (12): p. 2910-8.
86. Giordano, A., et al., Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res, 2013. 54 (9): p. 2423-36.
87. Murano, I., et al., Time course of histomorphological changes in adipose tissue upon acute lipoatrophy. NutrMetab Cardiovasc Dis, 2013. 23 (8): p. 723-31.
88. Miao, E.A., et al., Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol, 2010. 11 (12): p. 1136-1142.
89. Galluzzi, L., et al., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ, 2012. 19 (1): p. 107-20.
90. Hosogai, N., et al., Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes, 2007. 56 (4): p. 901-11.
91. Ye, J., et al., Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab, 2007. 293 (4): p. E1118-28.
92. Rausch, M.E., et al., Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond), 2008. 32 (3): p. 451-63.
93. Goossens, G.H., et al., Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation, 2011. 124 (1): p. 67-76.
94. Blaak, E.E., et al., β-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects. Metabolism, 1995. 44 (2): p. 183-187.
95. Trayhurn, P., Hypoxia and adipose tissue function and dysfunction in obesity. Physiological Reviews, 2013. 93 (1): p. 1-21.
96. Pasarica, M., et al., Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes, 2009. 58 (3): p. 718-725.
97. Yamauchi, T., et al., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001. 7 (8): p. 941-6.
98. Boden, G., et al., Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes, 2008. 57 (9): p. 2438-44.
99. Gregor, M.F., et al., Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes, 2009. 58 (3): p. 693-700.
100. Chen, B., et al., Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun, 2006. 341 (2): p. 549-56.
101. Lolmede, K., et al., Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord, 2003. 27 (10): p. 1187-95.
102. Wang, G.L. and G.L. Semenza, General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A, 1993. 90 (9): p. 4304-8.
103. Jiang, C., et al., Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes, 2011. 60 (10): p. 2484-2495.
104. Odegaard, J.I. and A. Chawla, Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science, 2013. 339 (6116): p. 172-7.
105. Trayhurn, P., Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev, 2013. 93 (1): p. 1-21.